Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases

Immune checkpoint inhibitor‐induced diabetes mellitus is a rare immune‐related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes.

Detalles Bibliográficos
Autores principales: Fujiwara, Noriko, Watanabe, Mayu, Katayama, Akihiro, Noda, Yohei, Eguchi, Jun, Kataoka, Hitomi, Kagawa, Shunsuke, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424178/
https://www.ncbi.nlm.nih.gov/pubmed/34522382
http://dx.doi.org/10.1002/ccr3.4574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424178/
https://www.ncbi.nlm.nih.gov/pubmed/34522382
http://dx.doi.org/10.1002/ccr3.4574

Ejemplares similares